New hope for leukemia patients: drug targets hidden cancer cells after transplant
NCT ID NCT05940961
First seen Nov 21, 2025 · Last updated May 20, 2026 · Updated 22 times
Summary
This study tests a drug called Inotuzumab Ozogamicin (INO) in people with acute lymphoblastic leukemia (ALL) who still have tiny amounts of leukemia cells (called minimal residual disease, or MRD) after a stem cell transplant. The goal is to see if INO can clear these leftover cells and help patients live longer without the cancer coming back. About 42 adults aged 15 to 65 will receive INO in 21-day cycles, and doctors will monitor for side effects and how well the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, Jiangsu, 215006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.